KPC Pharmaceuticals, Inc. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was CNY 7,717.086 million compared to CNY 8,119.963 million a year ago. Operating income was CNY 540.830 million compared to CNY 539.802 million a year ago. Net income was CNY 456.856 million compared to CNY 454.309 million a year ago. Basic earnings per share from continuing operations was CNY 0.6018 compared to CNY 0.5967 a year ago. Diluted earnings per share from continuing operations was CNY 0.6018 compared to CNY 0.5965 a year ago.